Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
This article reviews a range of issues associated with the commercialization of biomedical research and speculates on how these issues might apply to the neuroscience context. Drawing on existing studies of the impact of research commercialization activities on various areas of biotechnology research, the authors explore normative benchmarks for assessing and resolving issues likely to arise from the commercialization of neuroscientific research, including such topics as patenting, marketing pressures, and representations of research prospects.
Caulfield
Timothy
T
Health Law Institute, University of Alberta, Edmonton, Alberta, Canada. tcaulfld@law.ualberta.ca
Ogbogu
Ubaka
U
D035843:Biomedical Research / Q000191:economics / Q000941:ethics* / Q000592:standards; D001709:Biotechnology / Q000191:economics / Q000941:ethics* / Q000379:methods; D003132:Commerce / Q000191:economics / Q000941:ethics* / Q000592:standards; D006801:Humans; D007373:Interinstitutional Relations; D009488:Neurosciences / Q000191:economics / Q000941:ethics* / Q000592:standards; D010330:Patents as Topic; D017149:Private Sector; D017150:Public Sector